These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 14993880)

  • 21. The impact of early viral infections and graft-versus-host disease on immune reconstitution following paediatric stem cell transplantation.
    Olkinuora H; von Willebrand E; Kantele JM; Vainio O; Talvensaari K; Saarinen-Pihkala U; Siitonen S; Vettenranta K
    Scand J Immunol; 2011 Jun; 73(6):586-93. PubMed ID: 21323694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor.
    Walter EA; Greenberg PD; Gilbert MJ; Finch RJ; Watanabe KS; Thomas ED; Riddell SR
    N Engl J Med; 1995 Oct; 333(16):1038-44. PubMed ID: 7675046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adoptive immunotherapy of HCMV infection.
    Kapp M; Tan SM; Einsele H; Grigoleit G
    Cytotherapy; 2007; 9(8):699-711. PubMed ID: 17917875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CMV-, EBV- and ADV-specific T cell immunity: screening and monitoring of potential third-party donors to improve post-transplantation outcome.
    Sukdolak C; Tischer S; Dieks D; Figueiredo C; Goudeva L; Heuft HG; Verboom M; Immenschuh S; Heim A; Borchers S; Mischak-Weissinger E; Blasczyk R; Maecker-Kolhoff B; Eiz-Vesper B
    Biol Blood Marrow Transplant; 2013 Oct; 19(10):1480-92. PubMed ID: 23891747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BK virus-specific T cells for use in cellular therapy show specificity to multiple antigens and polyfunctional cytokine responses.
    Blyth E; Clancy L; Simms R; Gaundar S; O'Connell P; Micklethwaite K; Gottlieb DJ
    Transplantation; 2011 Nov; 92(10):1077-84. PubMed ID: 22002347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytotoxic T lymphocytes as immune-therapy in haematological practice.
    Leen AM; Heslop HE
    Br J Haematol; 2008 Oct; 143(2):169-79. PubMed ID: 18691164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD123 redirected multiple virus-specific T cells for acute myeloid leukemia.
    Zhou L; Liu X; Wang X; Sun Z; Song XT
    Leuk Res; 2016 Feb; 41():76-84. PubMed ID: 26740053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Principles for adoptive T cell therapy of human viral diseases.
    Riddell SR; Greenberg PD
    Annu Rev Immunol; 1995; 13():545-86. PubMed ID: 7612234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic reconstitution of human viral immunity by adoptive transfer of cytotoxic T lymphocyte clones.
    Riddell SR; Greenberg PD
    Curr Top Microbiol Immunol; 1994; 189():9-34. PubMed ID: 7924439
    [No Abstract]   [Full Text] [Related]  

  • 30. Cytomegalovirus-specific cytotoxic T lymphocytes can be efficiently expanded from granulocyte colony-stimulating factor-mobilized hemopoietic progenitor cell products ex vivo and safely transferred to stem cell transplantation recipients to facilitate immune reconstitution.
    Clancy LE; Blyth E; Simms RM; Micklethwaite KP; Ma CK; Burgess JS; Antonenas V; Shaw PJ; Gottlieb DJ
    Biol Blood Marrow Transplant; 2013 May; 19(5):725-34. PubMed ID: 23380344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epstein-Barr virus-specific cytotoxic T-lymphocytes for adoptive immunotherapy of post-transplant lymphoproliferative disease.
    Burns DM; Crawford DH
    Blood Rev; 2004 Sep; 18(3):193-209. PubMed ID: 15183903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cellular therapy of Epstein-Barr-virus-associated post-transplant lymphoproliferative disease.
    Heslop HE; Savoldo B; Rooney CM
    Best Pract Res Clin Haematol; 2004 Sep; 17(3):401-13. PubMed ID: 15498712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T-cell therapy for viral infections.
    Heslop HE; Leen AM
    Hematology Am Soc Hematol Educ Program; 2013; 2013():342-7. PubMed ID: 24319202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapidly generated multivirus-specific cytotoxic T lymphocytes for the prophylaxis and treatment of viral infections.
    Gerdemann U; Keirnan JM; Katari UL; Yanagisawa R; Christin AS; Huye LE; Perna SK; Ennamuri S; Gottschalk S; Brenner MK; Heslop HE; Rooney CM; Leen AM
    Mol Ther; 2012 Aug; 20(8):1622-32. PubMed ID: 22801446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early cytomegalovirus reactivation leaves a specific and dynamic imprint on the reconstituting T cell compartment long-term after hematopoietic stem cell transplantation.
    Lugthart G; van Ostaijen-Ten Dam MM; Jol-van der Zijde CM; van Holten TC; Kester MG; Heemskerk MH; Bredius RG; van Tol MJ; Lankester AC
    Biol Blood Marrow Transplant; 2014 May; 20(5):655-61. PubMed ID: 24462981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunotherapy to reconstitute immunity to DNA viruses.
    Gahn B; Hunt G; Rooney CM; Heslop HE
    Semin Hematol; 2002 Jan; 39(1):41-7. PubMed ID: 11799528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular immune therapy for viral infections in transplant patients.
    Khanna R; Smith C
    Indian J Med Res; 2013 Nov; 138(5):796-807. PubMed ID: 24434332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytomegalovirus-specific T cell immunotherapy promotes restoration of durable functional antiviral immunity following allogeneic stem cell transplantation.
    Peggs KS; Verfuerth S; Pizzey A; Chow SL; Thomson K; Mackinnon S
    Clin Infect Dis; 2009 Dec; 49(12):1851-60. PubMed ID: 19911966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human CD8+ memory and EBV-specific T cells show low alloreactivity in vitro and in CD34+ stem cell-engrafted NOD/SCID/IL-2Rγc null mice.
    Thomas S; Klobuch S; Sommer M; van Ewijk R; Theobald M; Meyer RG; Herr W
    Exp Hematol; 2014 Jan; 42(1):28-38.e1-2. PubMed ID: 24120693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infusion of cytotoxic T lymphocytes for the treatment of viral infections in hematopoetic stem cell transplant patients.
    Baugh KA; Tzannou I; Leen AM
    Curr Opin Infect Dis; 2018 Aug; 31(4):292-300. PubMed ID: 29750672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.